Non-ST-Segment Elevation Myocardial Infarction in Elderly Patients

The world population is aging, and cardiovascular diseases are the leading cause of death in Western countries. 

It is increasingly common to find patients aged 70 or older with non-ST-segment elevation acute myocardial infarction (NSTEMI). However, this group has been excluded from most studies, and there is not enough information to determine whether a conservative approach or invasive studies should be the preferred option.

Researchers conducted a meta-analysis including 1479 patients, half of whom underwent invasive treatment (INV) while the other half received conservative treatment (CON).

The primary endpoint (PEP) was all-cause mortality or myocardial infarction at one year of follow-up.

There were no significant differences in the studied population: the mean age was 84 years and 52% of patients were men; 79% had hypertension, 29% had diabetes, 15% had suffered a stroke, 35% had a previous myocardial infarction, 20% had undergone percutaneous coronary intervention (PCI), 13% had undergone myocardial revasculatization surgery, and 15% had atrial fibrillation.

Read also: QFR Analysis of Coronary Lesions with TAVR.

There were also no differences in the Killip classification at admission; most subjects were in Killip class 1.

The PEP at one year was similar between groups: 24.5% in the INV group and 28.9% in the CON group (95% confidence interval [CI]: 0.63–1.22; P = 0.43). There were no differences in mortality, but patients who received conservative treatment had a higher rate of myocardial infarction (19.1% vs. 12.2%, 95% CI 0.47–0.79; P = 0.0002) and a greater need for urgent revascularization (random-effects model hazard ratio [HR]: 0.41; 95% CI, 0.18–0.95; P = 0.037).

Conclusion

There was no evidence that routine invasive treatment in elderly patients with NSTEMI reduces the risk of all-cause mortality or myocardial infarction within one year compared with conservative treatment. However, there is compelling evidence that invasive treatment reduces the risk of recurrent myocardial infarction or need for urgent revascularization. More research through large-scale studies is needed.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.

Reference: Christos P. Kotanidis, et al. European Heart Journal (2024) 45, 2052–2062 https://doi.org/10.1093/eurheartj/ehae151


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...